{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:13:05Z","timestamp":1773000785066,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474247"],"award-info":[{"award-number":["82474247"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00438-025-02277-z","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:26:02Z","timestamp":1753878362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["DNA methylation biomarkers in diabetic kidney disease: insights and implications"],"prefix":"10.1007","volume":"300","author":[{"given":"Ziyi","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3226-4150","authenticated-orcid":false,"given":"Liang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"issue":"1","key":"2277_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13148-020-00896-4","volume":"12","author":"SAH Ahmed","year":"2020","unstructured":"Ahmed SAH, Ansari SA, Mensah-Brown EPK, Emerald BS (2020) The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus. Clin Epigenetics 12(1):104. https:\/\/doi.org\/10.1186\/s13148-020-00896-4. (published Online First: 2020\/07\/13)","journal-title":"Clin Epigenetics"},{"key":"2277_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122256","volume":"335","author":"V Akhouri","year":"2023","unstructured":"Akhouri V, Majumder S, Gaikwad AB (2023) Targeting DNA methylation in diabetic kidney disease: a new perspective. Life Sci 335:122256. https:\/\/doi.org\/10.1016\/j.lfs.2023.122256. (published Online First: 2023\/11\/11)","journal-title":"Life Sci"},{"issue":"12","key":"2277_CR3","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/cjn.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol 12(12):2032\u20132045. https:\/\/doi.org\/10.2215\/cjn.11491116. (published Online First: 2017\/05\/20)","journal-title":"Clin J Am Soc Nephrol"},{"key":"2277_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nbt.3605","volume":"34","author":"CFFSPYMABHCTD Assenov","year":"2016","unstructured":"Assenov CFFSPYMABHCTD, Bock C, Halbritter F et al (2016) Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. Nat Biotechnol 34:726\u2013737. https:\/\/doi.org\/10.1038\/nbt.3605","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2277_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.kint.2019.02.020","volume":"96","author":"G Chen","year":"2019","unstructured":"Chen G, Chen H, Ren S et al (2019a) Aberrant DNA methylation of mTOR pathway genes promotes inflammatory activation of immune cells in diabetic kidney disease. Kidney Int 96(2):409\u2013420. https:\/\/doi.org\/10.1016\/j.kint.2019.02.020. (published Online First: 2019\/05\/19)","journal-title":"Kidney Int"},{"issue":"4","key":"2277_CR6","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1021\/acsami.8b20144","volume":"11","author":"X Chen","year":"2019","unstructured":"Chen X, Huang J, Zhang S et al (2019b) Electrochemical biosensor for DNA methylation detection through hybridization chain-amplified reaction coupled with a tetrahedral DNA nanostructure. ACS Appl Mater Interfaces 11(4):3745\u20133752. https:\/\/doi.org\/10.1021\/acsami.8b20144. (published Online First: 2019\/01\/10)","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"2277_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000506634","volume":"6","author":"Y Chen","year":"2020","unstructured":"Chen Y, Lee K, Ni Z, He JC (2020) Diabetic kidney disease: challenges, advances, and opportunities. Kidney Dis (Basel) 6(4):215\u2013225. https:\/\/doi.org\/10.1159\/000506634. (published Online First: 2020\/09\/10)","journal-title":"Kidney Dis (Basel)"},{"issue":"748","key":"2277_CR8","doi-asserted-by":"publisher","first-page":"eadj3385","DOI":"10.1126\/scitranslmed.adj3385","volume":"16","author":"Z Chen","year":"2024","unstructured":"Chen Z, Satake E, Pezzolesi MG et al (2024) Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes. Sci Transl Med 16(748):eadj3385. https:\/\/doi.org\/10.1126\/scitranslmed.adj3385. (published Online First: 20240522)","journal-title":"Sci Transl Med"},{"issue":"6","key":"2277_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4239\/wjd.v5.i6.763","volume":"5","author":"G Currie","year":"2014","unstructured":"Currie G, McKay G, Delles C (2014) Biomarkers in diabetic nephropathy: present and future. World J Diabetes 5(6):763\u2013776. https:\/\/doi.org\/10.4239\/wjd.v5.i6.763. (published Online First: 2014\/12\/17)","journal-title":"World J Diabetes"},{"issue":"5","key":"2277_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","volume":"17","author":"RA DeFronzo","year":"2021","unstructured":"DeFronzo RA, Reeves WB, Awad AS (2021) Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat Rev Nephrol 17(5):319\u2013334","journal-title":"Nat Rev Nephrol"},{"key":"2277_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2019.111847","volume":"149","author":"Q Feng","year":"2020","unstructured":"Feng Q, Qin L, Wang M, Wang P (2020) Signal-on electrochemical detection of DNA methylation based on the target-induced conformational change of a DNA probe and exonuclease III-assisted target recycling. Biosens Bioelectron 149:111847. https:\/\/doi.org\/10.1016\/j.bios.2019.111847. (published Online First: 2019\/11\/17)","journal-title":"Biosens Bioelectron"},{"issue":"2","key":"2277_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s40620-023-01800-y","volume":"37","author":"S Frydman","year":"2024","unstructured":"Frydman S, Freund O, Zornitzki L et al (2024) Indexed neutrophil gelatinase associated lipocalin: a novel biomarker for the assessment of acute kidney injury. J Nephrol 37(2):401\u2013407. https:\/\/doi.org\/10.1007\/s40620-023-01800-y. (published Online First: 2023\/11\/02)","journal-title":"J Nephrol"},{"key":"2277_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.molmet.2019.10.005","volume":"30","author":"H Fu","year":"2019","unstructured":"Fu H, Liu S, Bastacky SI et al (2019) Diabetic kidney diseases revisited: a new perspective for a new era. Mol Metab 30:250\u2013263. https:\/\/doi.org\/10.1016\/j.molmet.2019.10.005. (published Online First: 2019\/11\/27)","journal-title":"Mol Metab"},{"key":"2277_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fendo.2015.00043","volume":"6","author":"L Gillberg","year":"2015","unstructured":"Gillberg L, Ling C (2015) The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes. Front Endocrinol (Lausanne) 6:43. https:\/\/doi.org\/10.3389\/fendo.2015.00043. (published Online First: 2015\/04\/15)","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2277_CR15","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41467-019-10378-8","volume":"10","author":"C Gluck","year":"2019","unstructured":"Gluck C, Qiu C, Han SY et al (2019) Kidney cytosine methylation changes improve renal function decline estimation in patients with diabetic kidney disease. Nat Commun 10(1):2461. https:\/\/doi.org\/10.1038\/s41467-019-10378-8. (published Online First: 2019\/06\/06)","journal-title":"Nat Commun"},{"key":"2277_CR16","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1534\/genetics.116.195594","volume":"206","author":"S Gopalan","year":"2016","unstructured":"Gopalan S, Carja O, Fagny M et al (2016) Trends in DNA methylation with age replicate across diverse human populations. Genetics 206:1659\u20131674. https:\/\/doi.org\/10.1534\/genetics.116.195594","journal-title":"Genetics"},{"issue":"1","key":"2277_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2337\/diacare.28.1.164","volume":"28","author":"JL Gross","year":"2005","unstructured":"Gross JL, de Azevedo MJ, Silveiro SP et al (2005) Diabetic Nephropathy: Diagnosis, Prevention, and Treatment. Diabetes Care 28(1):164\u2013176. https:\/\/doi.org\/10.2337\/diacare.28.1.164","journal-title":"Diabetes Care"},{"key":"2277_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bios.2018.12.022","volume":"127","author":"J Huang","year":"2019","unstructured":"Huang J, Zhang S, Mo F et al (2019) An electrochemical DNA biosensor analytic technique for identifying DNA methylation specific sites and quantify DNA methylation level. Biosens Bioelectron 127:155\u2013160. https:\/\/doi.org\/10.1016\/j.bios.2018.12.022. (published Online First: 2019\/01\/01)","journal-title":"Biosens Bioelectron"},{"issue":"21","key":"2277_CR19","doi-asserted-by":"publisher","first-page":"11857","DOI":"10.3390\/ijms222111857","volume":"22","author":"PH Hung","year":"2021","unstructured":"Hung PH, Hsu YC, Chen TH, Lin CL (2021) Recent advances in diabetic kidney diseases: from kidney injury to kidney fibrosis. Int J Mol Sci 22(21):11857. https:\/\/doi.org\/10.3390\/ijms222111857. (published Online First: 2021\/11\/14)","journal-title":"Int J Mol Sci"},{"key":"2277_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1601-3","author":"L Husquin","year":"2018","unstructured":"Husquin L, Rotival M, Fagny M et al (2018) Exploring the genetic basis of human population differences in DNA methylation and their causal impact on immune gene regulation. Genome Biol. https:\/\/doi.org\/10.1186\/s13059-018-1601-3","journal-title":"Genome Biol"},{"issue":"6","key":"2277_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","volume":"15","author":"M Kato","year":"2019","unstructured":"Kato M, Natarajan R (2019) Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat Rev Nephrol 15(6):327\u2013345. https:\/\/doi.org\/10.1038\/s41581-019-0135-6","journal-title":"Nat Rev Nephrol"},{"issue":"4s","key":"2277_CR22","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"KDIGO","year":"2024","unstructured":"KDIGO (2024) 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105(4s):S117-s314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"key":"2277_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110918","volume":"204","author":"I Khurana","year":"2023","unstructured":"Khurana I, Howard NJ, Maxwell S et al (2023) Circulating epigenomic biomarkers correspond with kidney disease susceptibility in high-risk populations with type 2 diabetes mellitus. Diabetes Res Clin Pract 204:110918. https:\/\/doi.org\/10.1016\/j.diabres.2023.110918. (published Online First: 20230924)","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"2277_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ekir.2020.03.006","volume":"5","author":"T Kimura","year":"2020","unstructured":"Kimura T, Snijder R, Nozaki K (2020) Diagnosis patterns of CKD and anemia in the Japanese population. Kidney Int Rep 5(5):694\u2013705. https:\/\/doi.org\/10.1016\/j.ekir.2020.03.006. (published Online First: 2020\/05\/15)","journal-title":"Kidney Int Rep"},{"issue":"5","key":"2277_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.ajkd.2018.02.364[publishedOnlineFirst:2018\/05\/23]","volume":"72","author":"DN Koye","year":"2018","unstructured":"Koye DN, Magliano DJ, Reid CM et al (2018) Risk of progression of nonalbuminuric CKD to end-stage kidney disease in people with diabetes: the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis 72(5):653\u2013661. https:\/\/doi.org\/10.1053\/j.ajkd.2018.02.364[publishedOnlineFirst:2018\/05\/23]","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2277_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrg2732","volume":"11","author":"PW Laird","year":"2010","unstructured":"Laird PW (2010) Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Genet 11(3):191\u2013203. https:\/\/doi.org\/10.1038\/nrg2732","journal-title":"Nat Rev Genet"},{"issue":"10","key":"2277_CR27","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1096\/fj.201800205R","volume":"32","author":"BP Larkin","year":"2018","unstructured":"Larkin BP, Glastras SJ, Chen H et al (2018) DNA methylation and the potential role of demethylating agents in prevention of progressive chronic kidney disease. FASEB J 32(10):5215\u20135226","journal-title":"FASEB J"},{"issue":"2","key":"2277_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190280","volume":"13","author":"A Lecamwasam","year":"2018","unstructured":"Lecamwasam A, Sexton-Oates A, Carmody J et al (2018) DNA methylation profiling of genomic DNA isolated from urine in diabetic chronic kidney disease: a pilot study. PLoS ONE 13(2):e0190280. https:\/\/doi.org\/10.1371\/journal.pone.0190280. (published Online First: 2018\/02\/21)","journal-title":"PLoS ONE"},{"issue":"7","key":"2277_CR29","doi-asserted-by":"publisher","DOI":"10.2196\/16277","volume":"9","author":"AR Lecamwasam","year":"2020","unstructured":"Lecamwasam AR, Mohebbi M, Ekinci EI et al (2020) Identification of potential biomarkers of chronic kidney disease in individuals with diabetes: protocol for a cross-sectional observational study. JMIR Res Protoc 9(7):e16277. https:\/\/doi.org\/10.2196\/16277. (published Online First: 2020\/08\/01)","journal-title":"JMIR Res Protoc"},{"issue":"11","key":"2277_CR30","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/ndt\/gfaa226","volume":"36","author":"A Lecamwasam","year":"2021","unstructured":"Lecamwasam A, Novakovic B, Meyer B et al (2021) DNA methylation profiling identifies epigenetic differences between early versus late stages of diabetic chronic kidney disease. Nephrol Dial Transplant 36(11):2027\u20132038","journal-title":"Nephrol Dial Transplant"},{"issue":"14","key":"2277_CR31","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1039\/c7cc08427g","volume":"54","author":"M Li","year":"2018","unstructured":"Li M, Zhang L, Chen G et al (2018) DNAzyme based visual detection of DNA methylation. Chem Commun (Camb) 54(14):1710\u20131713. https:\/\/doi.org\/10.1039\/c7cc08427g. (published Online First: 2017\/12\/08)","journal-title":"Chem Commun (Camb)"},{"issue":"1","key":"2277_CR32","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1038\/s41467-023-37837-7","volume":"14","author":"KY Li","year":"2023","unstructured":"Li KY, Tam CHT, Liu H et al (2023) DNA methylation markers for kidney function and progression of diabetic kidney disease. Nat Commun 14(1):2543. https:\/\/doi.org\/10.1038\/s41467-023-37837-7","journal-title":"Nat Commun"},{"issue":"1","key":"2277_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000381796","volume":"1","author":"R Liu","year":"2015","unstructured":"Liu R, Lee K, He JC (2015) Genetics and epigenetics of diabetic nephropathy. Kidney Dis (Basel) 1(1):42\u201351. https:\/\/doi.org\/10.1159\/000381796. (published Online First: 2015\/05\/01)","journal-title":"Kidney Dis (Basel)"},{"key":"2277_CR34","doi-asserted-by":"publisher","first-page":"1133970","DOI":"10.3389\/fendo.2023.1133970","volume":"14","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu J, Wang W et al (2023) Epigenetic modification in diabetic kidney disease. Front Endocrinol (Lausanne) 14:1133970. https:\/\/doi.org\/10.3389\/fendo.2023.1133970. (published Online First: 20230630)","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2277_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01150","author":"W Locke","year":"2019","unstructured":"Locke W, Guanzon D, Chenkai et al (2019) DNA methylation cancer biomarkers: translation to the clinic. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2019.01150","journal-title":"Front Genet"},{"key":"2277_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2020.12.011","author":"Hy Luo","year":"2021","unstructured":"Luo Hy, Wei W, Ye Z et al (2021) Liquid biopsy of methylation biomarkers in cell-free DNA. Trends Mol Med. https:\/\/doi.org\/10.1016\/j.molmed.2020.12.011","journal-title":"Trends Mol Med"},{"issue":"1","key":"2277_CR37","doi-asserted-by":"publisher","first-page":"2146512","DOI":"10.1080\/0886022X.2022.2146512","volume":"45","author":"X Ma","year":"2023","unstructured":"Ma X, Ma J, Leng T et al (2023) Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention. Ren Fail 45(1):2146512","journal-title":"Ren Fail"},{"issue":"18","key":"2277_CR38","doi-asserted-by":"publisher","first-page":"10322","DOI":"10.1111\/jcmm.15642","volume":"24","author":"N Mahmood","year":"2020","unstructured":"Mahmood N, Arakelian A, Cheishvili D et al (2020) S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis. J Cell Mol Med 24(18):10322\u201310337","journal-title":"J Cell Mol Med"},{"key":"2277_CR39","doi-asserted-by":"publisher","unstructured":"Mahmood N, Rabbani SA (2019) Targeting DNA hypomethylation in malignancy by epigenetic therapies. Adv Exp Med Biol 1164:179\u2013196. https:\/\/doi.org\/10.1007\/978-3-030-22254-3_14","DOI":"10.1007\/978-3-030-22254-3_14"},{"issue":"3","key":"2277_CR40","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1080\/10495398.2021.1981356","volume":"34","author":"S Malpotra","year":"2023","unstructured":"Malpotra S, Singh MK, Palta P (2023) MeDIP-sequencing for profiling global DNA methylation in buffalo embryos produced by in vitro fertilization. Anim Biotechnol 34(3):546\u2013562. https:\/\/doi.org\/10.1080\/10495398.2021.1981356. (published Online First: 2021\/10\/07)","journal-title":"Anim Biotechnol"},{"issue":"3","key":"2277_CR41","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2337\/db24-0483","volume":"74","author":"M Marchiori","year":"2025","unstructured":"Marchiori M, Maguolo A, Perfilyev A et al (2025) Blood-Based epigenetic biomarkers associated with incident chronic kidney disease in individuals with type 2 diabetes. Diabetes 74(3):439\u2013450. https:\/\/doi.org\/10.2337\/db24-0483","journal-title":"Diabetes"},{"issue":"10","key":"2277_CR42","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1681\/asn.2014070665","volume":"26","author":"T Marumo","year":"2015","unstructured":"Marumo T, Yagi S, Kawarazaki W et al (2015) Diabetes induces aberrant DNA methylation in the proximal tubules of the kidney. J Am Soc Nephrol 26(10):2388\u20132397. https:\/\/doi.org\/10.1681\/asn.2014070665. (published Online First: 2015\/02\/06)","journal-title":"J Am Soc Nephrol"},{"key":"2277_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001501","author":"T Marumo","year":"2020","unstructured":"Marumo T, Hoshino J, Kawarazaki W et al (2020) Methylation pattern of urinary DNA as a marker of kidney function decline in diabetes. BMJ Open Diabetes Res Care. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001501. (published Online First: 2020\/09\/05)","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2277_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/nu14040785","author":"LT Nguyen","year":"2022","unstructured":"Nguyen LT, Larkin BP, Wang R et al (2022) Blood DNA Methylation Predicts Diabetic Kidney Disease Progression in High Fat Diet-Fed Mice. Nutrients. https:\/\/doi.org\/10.3390\/nu14040785. (published Online First: 2022\/02\/27)","journal-title":"Nutrients"},{"key":"2277_CR45","doi-asserted-by":"publisher","first-page":"5432453","DOI":"10.1155\/2019\/5432453","volume":"2019","author":"A Onishi","year":"2019","unstructured":"Onishi A, Sugiyama H, Kitagawa M et al (2019) Urine 5MedC, a marker of DNA methylation, in the progression of chronic kidney disease. Dis Markers 2019:5432453. https:\/\/doi.org\/10.1155\/2019\/5432453. (published Online First: 2019\/07\/30)","journal-title":"Dis Markers"},{"key":"2277_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.12.011","author":"V Ortiz-Barahona","year":"2020","unstructured":"Ortiz-Barahona V, Joshi R, Esteller M (2020) Use of DNA methylation profiling in translational oncology. Semin Cancer Biol. https:\/\/doi.org\/10.1016\/j.semcancer.2020.12.011","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"2277_CR47","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/10408363.2017.1377682","volume":"54","author":"N Papadopoulou-Marketou","year":"2017","unstructured":"Papadopoulou-Marketou N, Kanaka-Gantenbein C, Marketos N et al (2017) Biomarkers of diabetic nephropathy: A 2017 update. Crit Rev Clin Lab Sci 54(5):326\u2013342. https:\/\/doi.org\/10.1080\/10408363.2017.1377682. (published Online First: 2017\/09\/29)","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2277_CR48","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128886","author":"J Park","year":"2019","unstructured":"Park J, Guan Y, Sheng X et al (2019) Functional methylome analysis of human diabetic kidney disease. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.128886. (published Online First: 2019\/06\/07)","journal-title":"JCI Insight"},{"issue":"5","key":"2277_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188941","volume":"1878","author":"S Peng","year":"2023","unstructured":"Peng S, Zhang X, Wu Y (2023) Potential applications of DNA methylation testing technology in female tumors and screening methods. Biochim Biophys Acta Rev Cancer 1878(5):188941. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188941. (published Online First: 2023\/06\/18)","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"2277_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.kisu.2017.10.003","volume":"8","author":"F Persson","year":"2018","unstructured":"Persson F, Rossing P (2018) Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int Suppl 8(1):2\u20137","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"2277_CR51","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13059-016-1066-1","volume":"17","author":"R Pidsley","year":"2016","unstructured":"Pidsley R, Zotenko E, Peters TJ et al (2016) Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol 17(1):208. https:\/\/doi.org\/10.1186\/s13059-016-1066-1. (published Online First: 2016\/10\/09)","journal-title":"Genome Biol"},{"issue":"6","key":"2277_CR52","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.kint.2018.01.036","volume":"93","author":"C Qiu","year":"2018","unstructured":"Qiu C, Hanson RL, Fufaa G et al (2018) Cytosine methylation predicts renal function decline in American Indians. Kidney Int 93(6):1417\u20131431. https:\/\/doi.org\/10.1016\/j.kint.2018.01.036. (published Online First: 20180427)","journal-title":"Kidney Int"},{"key":"2277_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111652","author":"GA Raciti","year":"2021","unstructured":"Raciti GA, Desiderio A, Longo M et al (2021) DNA methylation and type 2 diabetes: novel biomarkers for risk assessment? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222111652. (published Online First: 2021\/11\/14)","journal-title":"Int J Mol Sci"},{"key":"2277_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00011-020-01425-y","volume":"70","author":"O Ramos-Lopez","year":"2021","unstructured":"Ramos-Lopez O, Milagro FI, Riezu-Boj JI, Martinez JA (2021) Epigenetic signatures underlying inflammation: an interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition. Inflamm Res 70:29\u201349","journal-title":"Inflamm Res"},{"issue":"8","key":"2277_CR55","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.3390\/nu13082821","volume":"13","author":"L Rasmussen","year":"2021","unstructured":"Rasmussen L, Knorr S, Antoniussen CS et al (2021) The impact of lifestyle, diet and physical activity on epigenetic changes in the offspring\u2014a systematic review. Nutrients 13(8):2821","journal-title":"Nutrients"},{"issue":"1","key":"2277_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4161\/epi.6.1.13362","volume":"6","author":"C Sapienza","year":"2011","unstructured":"Sapienza C, Lee J, Powell J et al (2011) DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics 6(1):20\u201328. https:\/\/doi.org\/10.4161\/epi.6.1.13362. (published Online First: 2010\/12\/15)","journal-title":"Epigenetics"},{"issue":"12","key":"2277_CR57","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1038\/s41596-022-00741-3","volume":"17","author":"DM Sapozhnikov","year":"2022","unstructured":"Sapozhnikov DM, Szyf M (2022) Enzyme-free targeted DNA demethylation using CRISPR\u2013dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression. Nat Protoc 17(12):2840\u20132881","journal-title":"Nat Protoc"},{"issue":"46","key":"2277_CR58","doi-asserted-by":"publisher","first-page":"29013","DOI":"10.1073\/pnas.2005905117","volume":"117","author":"X Sheng","year":"2020","unstructured":"Sheng X, Qiu C, Liu H et al (2020) Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease. Proc Natl Acad Sci U S A 117(46):29013\u201329024. https:\/\/doi.org\/10.1073\/pnas.2005905117. (published Online First: 2020\/11\/05)","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2277_CR59","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41392-022-01300-8","volume":"8","author":"F Shu","year":"2023","unstructured":"Shu F, Xiao H, Li QN et al (2023) Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets. Signal Transduct Target Ther 8(1):32. https:\/\/doi.org\/10.1038\/s41392-022-01300-8. (published Online First: 2023\/01\/17)","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2277_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrg3354","volume":"14","author":"ZD Smith","year":"2013","unstructured":"Smith ZD, Meissner A (2013) DNA methylation: roles in mammalian development. Nat Rev Genet 14(3):204\u2013220. https:\/\/doi.org\/10.1038\/nrg3354. (published Online First: 2013\/02\/13)","journal-title":"Nat Rev Genet"},{"key":"2277_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.561907","volume":"8","author":"LJ Smyth","year":"2020","unstructured":"Smyth LJ, Patterson CC, Swan EJ et al (2020) DNA methylation associated with diabetic kidney disease in blood-derived DNA. Front Cell Dev Biol 8:561907. https:\/\/doi.org\/10.3389\/fcell.2020.561907. (published Online First: 2020\/11\/13)","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2277_CR62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13148-021-01081-x","volume":"13","author":"LJ Smyth","year":"2021","unstructured":"Smyth LJ, Kilner J, Nair V et al (2021) Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study. Clin Epigenet 13(1):99. https:\/\/doi.org\/10.1186\/s13148-021-01081-x. (published Online First: 2021\/05\/03)","journal-title":"Clin Epigenet"},{"issue":"13","key":"2277_CR63","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/bioinformatics\/btu126","volume":"30","author":"PA Stockwell","year":"2014","unstructured":"Stockwell PA, Chatterjee A, Rodger EJ, Morison IM (2014) DMAP: differential methylation analysis package for RRBS and WGBS data. Bioinformatics 30(13):1814\u20131822. https:\/\/doi.org\/10.1093\/bioinformatics\/btu126. (published Online First: 2014\/03\/13)","journal-title":"Bioinformatics"},{"issue":"4","key":"2277_CR64","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1262\/jrd.2018-146","volume":"65","author":"K Takeda","year":"2019","unstructured":"Takeda K, Kobayashi E, Nishino K et al (2019) Age-related changes in DNA methylation levels at CpG sites in bull spermatozoa and in vitro fertilization-derived blastocyst-stage embryos revealed by combined bisulfite restriction analysis. J Reprod Dev 65(4):305\u2013312. https:\/\/doi.org\/10.1262\/jrd.2018-146. (published Online First: 2019\/05\/08)","journal-title":"J Reprod Dev"},{"issue":"4","key":"2277_CR65","doi-asserted-by":"publisher","first-page":"356","DOI":"10.21608\/aeji.2024.392499","volume":"14","author":"S Tawfik","year":"2024","unstructured":"Tawfik S, Elbatae HE (2024) Role of epigenetics in type 2 diabetes mellitus in tropics\u202c. Afro-Egypt J Infect Endemic Dis 14(4):356\u2013374","journal-title":"Afro-Egypt J Infect Endemic Dis"},{"issue":"3","key":"2277_CR66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11892-016-0723-9","volume":"16","author":"MC Thomas","year":"2016","unstructured":"Thomas MC (2016) Epigenetic mechanisms in diabetic kidney disease. Curr DiabRep 16(3):31. https:\/\/doi.org\/10.1007\/s11892-016-0723-9","journal-title":"Curr DiabRep"},{"issue":"6","key":"2277_CR67","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1096\/fj.201601059RR","volume":"31","author":"P Vineis","year":"2017","unstructured":"Vineis P, Chatziioannou A, Cunliffe VT et al (2017) Epigenetic memory in response to environmental stressors. FASEB J 31(6):2241\u20132251","journal-title":"FASEB J"},{"issue":"2","key":"2277_CR68","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00125-017-4497-7","volume":"61","author":"E Walaszczyk","year":"2018","unstructured":"Walaszczyk E, Luijten M, Spijkerman AMW et al (2018) DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA(1c) levels: a systematic review and replication in a case-control sample of the Lifelines study. Diabetologia 61(2):354\u2013368. https:\/\/doi.org\/10.1007\/s00125-017-4497-7. (published Online First: 2017\/11\/23)","journal-title":"Diabetologia"},{"key":"2277_CR69","doi-asserted-by":"publisher","first-page":"1206504","DOI":"10.3389\/fimmu.2023.1206504","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yang W, Wang Q, Zhou Y (2023) Mechanisms of esophageal cancer metastasis and treatment progress. Front Immunol 14:1206504. https:\/\/doi.org\/10.3389\/fimmu.2023.1206504. (published Online First: 2023\/06\/26)","journal-title":"Front Immunol"},{"key":"2277_CR70","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3389\/fendo.2018.00744","volume":"9","author":"T Willmer","year":"2018","unstructured":"Willmer T, Johnson R, Louw J, Pheiffer C (2018) Blood-based DNA methylation biomarkers for type 2 diabetes: potential for clinical applications. Front Endocrinol (Lausanne) 9:744. https:\/\/doi.org\/10.3389\/fendo.2018.00744. (published Online First: 2018\/12\/20)","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2277_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad923","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Zhou Q, Sun Y et al (2023) MethMarkerDB: a comprehensive cancer DNA methylation biomarker database. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkad923","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-025-02277-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-025-02277-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-025-02277-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:58:16Z","timestamp":1757318296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-025-02277-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2277"],"URL":"https:\/\/doi.org\/10.1007\/s00438-025-02277-z","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest in relation to this work. This research was conducted independently, and no financial or personal relationships with organizations or individuals could have influenced the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"73"}}